Follow the twists and turns of the orphan drug industry over the past three decades. Key moments in the history of orphan drugs range from a pivotal TV show to the AIDS crisis and a private meeting in a bathroom on Capitol Hill.
Timeline Contributors: Emily Kopp, Sydney Lupkin, Sarah Jane Tribble and Lydia Zuraw
KHN’s coverage of prescription drug development, costs and pricing is supported in part by the Laura and John Arnold Foundation.
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact firstname.lastname@example.org.